Jeffrey Roy Bruhjell serves as Executive at Global Immune Technologies Inc., where they oversee executive responsibilities. Since joining the company, Jeffrey Roy Bruhjell has executed 2 insider transactions totaling $132.0K, demonstrating a bullish approach to their equity position. Their most recent transaction on Dec 3, 2013 involved purchasing 3,300,000 shares valued at $66.0K.
Jeffrey Roy Bruhjell currently holds 2,394,508 shares of Global Immune Technologies Inc. (GIMU), valued at approximately $0. This represents their equity stake as Executive.
Based on SEC Form 4 filings, Jeffrey Roy Bruhjell has been a net buyer of GIMU stock. They have purchased $132.0K and sold $0 worth of shares.
Jeffrey Roy Bruhjell's most recent insider trade was on Dec 3, 2013, when they purchased 3,300,000 shares at $0.02 per share.
Get notified when new Form 4 filings are submitted
| $0.02 |
| Discretionary |